Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can cancer patients test their own blood at home?

NCT ID NCT06134245

Diagnosis Sponsor: Entia Ltd Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 11, 2026 · Last updated Sep 11, 2026

Summary

Researchers are studying whether the Entia Liberty, a home blood testing device, is easy and safe for cancer patients to use on their own. Participants are adults receiving systemic anti-cancer therapy who can read English and give consent. The trial measures how well patients operate the device and whether the results it produces are valid and reliable.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Entia Liberty home blood analyser
What this could lead to
If the device works well at home, cancer patients might one day check their blood counts without travelling to a clinic for every test.
What could go wrong
This is an early usability study with no participants enrolled yet. The device may prove hard to use or unreliable outside a clinic, and it is not meant to replace professional medical advice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Expected to start

Mar 2024

An estimate. Start dates often move.

Expected to finish

Jun 2024

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults with a diagnosis of solid tumour cancer, who are currently undergoing systemic anti-cancer therapy

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Undergoing systemic anti-cancer therapy (SACT) * Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, 2 at enrolment * Adequate English language skills (not requiring a translator) to participate in participant training and use the Entia Liberty analyser * Patients capable of providing written informed consent Exclusion Criteria: * History or current diagnosis of haematological malignancy * Patients with eyesight or hearing limitations or other disabilities that preclude the use of the Entia Liberty analyser or participation in training * Inadequate use and understanding of the English language, requiring a translator

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer

More trials for these conditions

Other studies related to the condition(s) this trial covers.